{"count":220790,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1985","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1983","results":[{"created":"2020-01-15T07:54:52.315394+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: WDR34 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"WDR34","entity_type":"gene"},{"created":"2020-01-15T07:53:42.944062+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: XPNPEP3 were changed from Nephronophthisis-like nephropathy 1, OMIM #613159 to Nephronophthisis-like nephropathy 1, OMIM #613159","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:53:42.367212+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: XPNPEP3 as ready","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:53:42.355370+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: xpnpep3 has been classified as Red List (Low Evidence).","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:52:52.166816+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: XPNPEP3 were changed from  to Nephronophthisis-like nephropathy 1, OMIM #613159","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:52:16.985617+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: XPNPEP3 were set to ","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:51:18.171063+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: XPNPEP3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"XPNPEP3","entity_type":"gene"},{"created":"2020-01-15T07:50:17.405853+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: C2CD3 as ready","entity_name":"C2CD3","entity_type":"gene"},{"created":"2020-01-15T07:50:17.393795+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: c2cd3 has been classified as Red List (Low Evidence).","entity_name":"C2CD3","entity_type":"gene"},{"created":"2020-01-15T07:50:10.704406+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: C2CD3 were changed from Orofaciodigital syndrome XIV, MIM# 615948 to Orofaciodigital syndrome XIV, MIM# 615948","entity_name":"C2CD3","entity_type":"gene"},{"created":"2020-01-15T07:49:26.833657+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.69","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: C2CD3 were changed from  to Orofaciodigital syndrome XIV, MIM# 615948","entity_name":"C2CD3","entity_type":"gene"},{"created":"2020-01-15T07:48:46.612775+11:00","panel_name":"Renal ciliopathies and nephronophthisis_KidGen_VCGS","panel_id":193,"panel_version":"0.68","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: C2CD3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"C2CD3","entity_type":"gene"},{"created":"2020-01-15T07:44:40.708061+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL4A1 as ready","entity_name":"COL4A1","entity_type":"gene"},{"created":"2020-01-15T07:44:40.696809+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col4a1 has been classified as Green List (High Evidence).","entity_name":"COL4A1","entity_type":"gene"},{"created":"2020-01-15T07:44:34.096707+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL4A1 were changed from  to Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, MIM#611773","entity_name":"COL4A1","entity_type":"gene"},{"created":"2020-01-15T07:43:39.729991+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL4A1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"COL4A1","entity_type":"gene"},{"created":"2020-01-15T07:42:41.034070+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CUBN as ready","entity_name":"CUBN","entity_type":"gene"},{"created":"2020-01-15T07:42:41.021223+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cubn has been classified as Red List (Low Evidence).","entity_name":"CUBN","entity_type":"gene"},{"created":"2020-01-15T07:42:24.872254+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FN1 as ready","entity_name":"FN1","entity_type":"gene"},{"created":"2020-01-15T07:42:24.860908+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fn1 has been classified as Red List (Low Evidence).","entity_name":"FN1","entity_type":"gene"},{"created":"2020-01-15T07:42:03.254579+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LMX1B as ready","entity_name":"LMX1B","entity_type":"gene"},{"created":"2020-01-15T07:42:03.242876+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lmx1b has been classified as Red List (Low Evidence).","entity_name":"LMX1B","entity_type":"gene"},{"created":"2020-01-15T07:41:45.686425+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPHS2 as ready","entity_name":"NPHS2","entity_type":"gene"},{"created":"2020-01-15T07:41:45.674977+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphs2 has been classified as Red List (Low Evidence).","entity_name":"NPHS2","entity_type":"gene"},{"created":"2020-01-15T07:41:25.616074+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OCRL as ready","entity_name":"OCRL","entity_type":"gene"},{"created":"2020-01-15T07:41:25.600014+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ocrl has been classified as Red List (Low Evidence).","entity_name":"OCRL","entity_type":"gene"},{"created":"2020-01-15T07:40:47.677791+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR5 as ready","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-01-15T07:40:47.666281+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr5 has been classified as Red List (Low Evidence).","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-01-15T07:40:21.784274+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR5 were changed from Nephropathy due to CFHR5 deficiency, MIM#614809 to Nephropathy due to CFHR5 deficiency, MIM#614809","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-01-15T07:39:39.206206+11:00","panel_name":"Haematuria_VCGS_KidGen","panel_id":39,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR5 were changed from  to Nephropathy due to CFHR5 deficiency, MIM#614809","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-01-15T07:37:23.888437+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADAMTS13 as ready","entity_name":"ADAMTS13","entity_type":"gene"},{"created":"2020-01-15T07:37:23.877129+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adamts13 has been classified as Amber List (Moderate Evidence).","entity_name":"ADAMTS13","entity_type":"gene"},{"created":"2020-01-15T07:37:16.471854+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADAMTS13 were changed from Thrombotic thrombocytopenic purpura, familial, OMIM #274150 to Thrombotic thrombocytopenic purpura, familial, OMIM #274150","entity_name":"ADAMTS13","entity_type":"gene"},{"created":"2020-01-15T07:36:33.664876+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADAMTS13 were changed from  to Thrombotic thrombocytopenic purpura, familial, OMIM #274150","entity_name":"ADAMTS13","entity_type":"gene"},{"created":"2020-01-15T07:35:55.255050+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ADAMTS13 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ADAMTS13","entity_type":"gene"},{"created":"2020-01-15T07:34:41.428029+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: THBD as ready","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:34:41.416361+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: thbd has been classified as Amber List (Moderate Evidence).","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:34:38.157185+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: THBD were changed from {Hemolytic uremic syndrome, atypical, susceptibility to, 6}; OMIM #612926 to {Hemolytic uremic syndrome, atypical, susceptibility to, 6}; OMIM #612926","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:34:03.046393+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: THBD were changed from  to {Hemolytic uremic syndrome, atypical, susceptibility to, 6}; OMIM #612926","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:33:26.652647+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: THBD were set to ","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:32:52.481276+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: THBD was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:31:23.496092+11:00","panel_name":"Atypical Haemolytic Uraemic Syndrome_MPGN_KidGen_VCGS_RMH","panel_id":211,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: THBD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"THBD","entity_type":"gene"},{"created":"2020-01-15T07:26:31.789733+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.791","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: JAM2 as ready","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:26:31.778401+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.791","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: jam2 has been classified as Green List (High Evidence).","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:26:23.261991+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.791","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: JAM2 as Green List (high evidence)","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:26:23.250543+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.791","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: jam2 has been classified as Green List (High Evidence).","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:26:02.121091+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.790","user_name":"Zornitza Stark","item_type":"entity","text":"gene: JAM2 was added\ngene: JAM2 was added to Mendeliome_VCGS. Sources: Literature\nMode of inheritance for gene: JAM2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: JAM2 were set to 31851307\nPhenotypes for gene: JAM2 were set to Primary brain calcification\nReview for gene: JAM2 was set to GREEN\nAdded comment: Three unrelated families with bi-allelic variants reported. The clinical phenotypes of the four patients included parkinsonism (3/4), dysarthria (3/4), seizures (1/4), and probable asymptomatic (1/4), with diverse onset ages. \nSources: Literature","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:23:41.311064+11:00","panel_name":"Brain calcification_VCGS","panel_id":58,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: JAM2 as ready","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:23:41.299830+11:00","panel_name":"Brain calcification_VCGS","panel_id":58,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: jam2 has been classified as Green List (High Evidence).","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:23:36.628384+11:00","panel_name":"Brain calcification_VCGS","panel_id":58,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: JAM2 as Green List (high evidence)","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:23:36.617009+11:00","panel_name":"Brain calcification_VCGS","panel_id":58,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: jam2 has been classified as Green List (High Evidence).","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:23:00.784833+11:00","panel_name":"Brain calcification_VCGS","panel_id":58,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"gene: JAM2 was added\ngene: JAM2 was added to Brain calcification_VCGS. Sources: Literature\nMode of inheritance for gene: JAM2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: JAM2 were set to 31851307\nPhenotypes for gene: JAM2 were set to Primary brain calcification\nAdded comment: Three unrelated families with bi-allelic variants reported. The clinical phenotypes of the four patients included parkinsonism (3/4), dysarthria (3/4), seizures (1/4), and probable asymptomatic (1/4), with diverse onset ages. \nSources: Literature","entity_name":"JAM2","entity_type":"gene"},{"created":"2020-01-15T07:16:49.673194+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1586","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FAM160B1 as ready","entity_name":"FAM160B1","entity_type":"gene"},{"created":"2020-01-15T07:16:49.661430+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1586","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fam160b1 has been classified as Red List (Low Evidence).","entity_name":"FAM160B1","entity_type":"gene"},{"created":"2020-01-14T21:40:35.578205+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1586","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CLCNKB as ready","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:40:35.566478+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1586","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: clcnkb has been classified as Green List (High Evidence).","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:38:45.772712+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1586","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CLCNKB were changed from Bartter syndrome, type 3, MIM#607364; Bartter syndrome, type 4b, digenic, MIM#613090 to Bartter syndrome, type 3, MIM#607364; Bartter syndrome, type 4b, digenic, MIM#613090","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:38:16.399897+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1585","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CLCNKB were changed from  to Bartter syndrome, type 3, MIM#607364; Bartter syndrome, type 4b, digenic, MIM#613090","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:37:32.212052+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1584","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AP1B1 as ready","entity_name":"AP1B1","entity_type":"gene"},{"created":"2020-01-14T21:37:32.200402+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1584","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ap1b1 has been classified as Green List (High Evidence).","entity_name":"AP1B1","entity_type":"gene"},{"created":"2020-01-14T21:37:04.119253+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1584","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CLCNKA as ready","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:37:04.106581+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1584","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: clcnka has been classified as Green List (High Evidence).","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:36:50.707717+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1584","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CLCNKB were set to ","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:36:20.718742+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1583","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CLCNKB was changed from Unknown to Other","entity_name":"CLCNKB","entity_type":"gene"},{"created":"2020-01-14T21:35:29.273681+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1582","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CLCNKA were changed from  to Bartter syndrome, type 4b, digenic, MIM#613090","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:35:17.993225+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1582","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COASY as ready","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:35:17.979899+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1582","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: coasy has been classified as Green List (High Evidence).","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:35:07.169478+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1582","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CLCNKA were set to ","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:34:45.268398+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1581","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CLCNKA was changed from Other to Other","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:34:21.974578+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1581","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CLCNKA was changed from Unknown to Other","entity_name":"CLCNKA","entity_type":"gene"},{"created":"2020-01-14T21:32:59.848153+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1580","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COASY were changed from Neurodegeneration with brain iron accumulation 6 615643; Pontocerebellar hypoplasia, type 12 618266 to Neurodegeneration with brain iron accumulation 6 615643; Pontocerebellar hypoplasia, type 12 618266","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:32:33.303048+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1580","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COG6 were changed from Congenital disorder of glycosylation, type Iil, MIM#614576 to Congenital disorder of glycosylation, type Iil, MIM#614576","entity_name":"COG6","entity_type":"gene"},{"created":"2020-01-14T21:32:10.299042+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1579","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COG6 as ready","entity_name":"COG6","entity_type":"gene"},{"created":"2020-01-14T21:32:09.584884+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1579","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cog6 has been classified as Green List (High Evidence).","entity_name":"COG6","entity_type":"gene"},{"created":"2020-01-14T21:32:04.854739+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1579","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COASY were changed from  to Neurodegeneration with brain iron accumulation 6 615643; Pontocerebellar hypoplasia, type 12 618266","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:31:37.609036+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1579","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: COASY were set to 24360804; 30089828","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:31:11.547597+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1579","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COG6 were changed from  to Congenital disorder of glycosylation, type Iil, MIM#614576","entity_name":"COG6","entity_type":"gene"},{"created":"2020-01-14T21:30:48.738050+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1578","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: COASY were set to ","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:30:20.933492+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1578","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COASY was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"COASY","entity_type":"gene"},{"created":"2020-01-14T21:29:25.163941+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1577","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COG6 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"COG6","entity_type":"gene"},{"created":"2020-01-14T21:29:18.236871+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1576","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COQ9 as ready","entity_name":"COQ9","entity_type":"gene"},{"created":"2020-01-14T21:29:18.223863+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1576","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: coq9 has been classified as Green List (High Evidence).","entity_name":"COQ9","entity_type":"gene"},{"created":"2020-01-14T21:28:26.270038+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1576","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COQ9 were changed from  to Coenzyme Q10 deficiency, primary, 5, MIM#614654","entity_name":"COQ9","entity_type":"gene"},{"created":"2020-01-14T21:27:55.678868+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1575","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COQ9 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"COQ9","entity_type":"gene"},{"created":"2020-01-14T21:26:33.662603+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFA as ready","entity_name":"ETFA","entity_type":"gene"},{"created":"2020-01-14T21:26:33.650990+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfa has been classified as Green List (High Evidence).","entity_name":"ETFA","entity_type":"gene"},{"created":"2020-01-14T21:25:55.803885+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFDH as ready","entity_name":"ETFDH","entity_type":"gene"},{"created":"2020-01-14T21:25:55.788672+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfdh has been classified as Green List (High Evidence).","entity_name":"ETFDH","entity_type":"gene"},{"created":"2020-01-14T21:25:15.054431+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FARS2 as ready","entity_name":"FARS2","entity_type":"gene"},{"created":"2020-01-14T21:25:15.036561+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fars2 has been classified as Green List (High Evidence).","entity_name":"FARS2","entity_type":"gene"},{"created":"2020-01-14T21:24:45.505768+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAP1B as ready","entity_name":"MAP1B","entity_type":"gene"},{"created":"2020-01-14T21:24:45.494627+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: map1b has been classified as Green List (High Evidence).","entity_name":"MAP1B","entity_type":"gene"},{"created":"2020-01-14T21:24:17.196715+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KLF7 as ready","entity_name":"KLF7","entity_type":"gene"},{"created":"2020-01-14T21:24:17.184956+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: klf7 has been classified as Green List (High Evidence).","entity_name":"KLF7","entity_type":"gene"},{"created":"2020-01-14T21:23:54.659748+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1574","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAP1B were changed from  to Intellectual disability; seizures; PVNH; dysmorphic features","entity_name":"MAP1B","entity_type":"gene"},{"created":"2020-01-14T21:23:26.665334+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1573","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MAP1B were set to ","entity_name":"MAP1B","entity_type":"gene"},{"created":"2020-01-14T21:22:53.749122+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1572","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MAP1B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MAP1B","entity_type":"gene"},{"created":"2020-01-14T21:21:56.691656+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1571","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MED17 as ready","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-14T21:21:56.680364+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1571","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: med17 has been classified as Green List (High Evidence).","entity_name":"MED17","entity_type":"gene"},{"created":"2020-01-14T21:21:42.689240+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ_VCGS","panel_id":250,"panel_version":"0.1571","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MED17 were changed from  to Microcephaly, postnatal progressive, with seizures and brain atrophy, MIM#613668","entity_name":"MED17","entity_type":"gene"}]}